Drugs Associated with Death Side Effect


Although all health products are carefully tested before they are licensed for sale, they can carry various risks. Some side effects may only become evident after a product is in use by the general population.

The following drugs are associated with Death (click on the link below to view detailed reports):

Drug Name Death Reports All Reports
Thalomid 2490 17203
Revlimid 2382 67826
Avandia 2077 97096
Exjade 1722 22177
Sutent 1624 30373
Tracleer 1435 28883
Remodulin 1269 4693
Letairis 1260 23161
Vioxx 1140 163906
Avonex 1051 158045
Forteo 990 61427
Avastin 916 23862
Enbrel 872 266818
Glivec 777 3364
Seroquel 753 83831
Xeloda 734 13502
Remicade 695 88892
Clozapine 679 14080
Trasylol 583 13230
Aclasta 564 13143
Aranesp 561 7254
Zometa 556 44191
Tysabri 555 196525
Capecitabine 539 13783
Humira 484 272927
Lipitor 476 48673
Exelon 469 11196
Gleevec 469 19929
Revatio 463 5245
Votrient 429 6221
Xtandi 423 3965
Fosamax 419 108140
Fentanyl 415 26403
Nexavar 408 35792
Morphine 402 14755
Diazepam 378 8033
Lucentis 378 7654
Tykerb 372 11378
Procrit 369 6845
Tyvaso 366 2791
1 of 57  View All


DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Death Reports Submitted to FDA

The following Death Side Effect Reports were submitted to FDA by healthcare professionals (physicians, pharmacists, and nurses), consumers (patients, family members, and lawyers) and manufacturers.

This information could help you understand how symptoms, such as Death could occur, develop and what you can do about them.

Hip Fracture, Fall

This is a report of a female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: multiple myeloma, who was treated with Thalomid (dosage: 50 Milligram, start time: Apr 14, 2011), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hip Fracture
  • Fall
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Thalomid treatment in female patients, resulting in Death side effect.

This report suggests a potential Revlimid side effect(s) that can have serious consequences. A patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: multiple myeloma and used Revlimid (dosage: 25 Milligram) starting May 11, 2011. Soon after starting Revlimid the patient began experiencing various side effects, including:
    Drugs used concurrently:
    • Coumadin (4 Milligram)
    • Nexium (20 Milligram)
    • Cholecalciferol (400 Units/ml)
    • Lyrica (25 Milligram)
    Although Revlimid demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
    Vascular Dementia, Cerebrovascular Accident, Cardiac Disorder, Asthenia, Weight Decreased, Transient Ischaemic Attack

    This Vascular Dementia, Cerebrovascular Accident, Cardiac Disorder, Asthenia, Weight Decreased, Transient Ischaemic Attack problem was reported by a consumer or non-health professional from UNITED STATES. A 84-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: diabetes mellitus. On Mar 01, 2004 this consumer started treatment with Avandia (dosage: 4mg Per Day). The following drugs were being taken at the same time: NA. When commencing Avandia, the patient experienced the following unwanted symptoms/side effects:
    • Vascular Dementia
    • Cerebrovascular Accident
    • Cardiac Disorder
    • Asthenia
    • Weight Decreased
    • Transient Ischaemic Attack
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.

    This is a report of a patient (weight: NA) from KOREA, REPUBLIC OF. The patient developed the following symptoms/conditions: iron overload and was treated with Exjade (dosage: 20 Mg/kg, Unk) starting Jun 11, 2008. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
      This opens a possibility that Exjade treatment could cause the above reactions, including Death, and some subjects may be more susceptible.

      A 57-year-old patient (weight: NA) from TAIWAN, PROVINCE OF CHINA with the following symptoms/conditions: renal cell carcinoma started Sutent treatment (dosage: 50 Mg, 1x/day) on Jun 08, 2011. Soon after starting Sutent treatment, the subject experienced various side effects, including:
        Concurrently used drugs: NA. This finding indicates that some patients could be more vulnerable to Sutent.
        Atrial Fibrillation, Right Ventricular Failure

        A 53-year-old patient from UNITED STATES (weight: NA) experienced symptoms, such as: pulmonary hypertension and was treated with Tracleer(dosage: Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
        • Atrial Fibrillation
        • Right Ventricular Failure
        Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Tracleer efficacy: NA.

        In this report, Remodulin was administered for the following condition: pulmonary arterial hypertension.A 77-year-old consumer from UNITED STATES (weight: NA) started Remodulin treatment (dosage: 95.04 Ug/kg (0.066 Ug/kg, 1 In 1 Min), Intravenous) on Dec 10, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
          A possible interaction with other drugs could have contributed to this reaction:
          • Diuretics (diuretics)
          Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Remodulin treatment could be related to the listed above side effect(s).
          Malaise

          This is a report of the following Letairis side effect(s):
          • Malaise
          A 84-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: pulmonary hypertension and received a treatment with Letairis (dosage: 5 Mg, Unk) starting: Dec 23, 2011.The following concurrently used drugs could have generated interactions:
          • Compazine Spansule
          • Ondansetron
          • Aggrenox
          • Lasix
          • Inderal
          • Ativan
          • Levothroid
          This report suggests that a Letairis treatment could be associated with the listed above side effect(s).
          Myocardial Infarction

          This Vioxx report was submitted by a 77-year-old consumer from UNITED STATES (weight: NA). The patient was diagnosed with: back pain and Vioxx was administered (dosage: NA) starting: Jan 01, 2001. The consumer developed a set of symptoms:
          • Myocardial Infarction
          Other drugs used simultaneously:
          • Diovan
          • Doxazosin Mesylate
          • Aspirin
          • Plavix
          • Zocor
          • Maalox Plus
          • Klonopin
          • Trazodone Hydrochloride
          Those unexpected symptoms could be linked to a Vioxx treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

          This is a report of a possible correlation between Avonex use and the following symptoms/side effect(s):
            which could contribute to an assessment of Avonex risk profile.A 40-year-old female consumer from UNITED STATES (weight: NA) was suffering from multiple sclerosis and was treated with Avonex (dosage: NA) starting Apr 02, 2004.Other concurrent medications:
            • Tysabri
            Asthma

            A 76-year-old patient from CANADA (weight: NA) presented with the following symptoms: osteoporosis and after a treatment with Forteo (dosage: 20 Ug, Qd) experienced the following side effect(s):
            • Asthma
            The treatment was started on Oct 17, 2011. Forteo was used in combination with the following drugs:
            • Prednisone
            • Ativan
            • Biocal-d
            • Ventolin
            • Symbicort
            This report could alert potential Forteo consumers.

            In this report, a female patient from GERMANY (weight: NA) was affected by a possible Avastin side effect.The patient was diagnosed with breast cancer. After a treatment with Avastin (dosage: NA, start date: Feb 28, 2011), the patient experienced the following side effect(s):
              The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Avastin treatment.

              This is a report of a 69-year-old patient from UNITED STATES (weight: NA), who used Enbrel (dosage: 50 Mg, Qwk) for a treatment of rheumatoid arthritis. After starting a treatment on Jul 13, 2010, the patient experienced the following side effect(s):
                The following drugs could possibly have interacted with the Enbrel treatment NA.Taken together, these observations suggest that a Enbrel treatment could be related to side effect(s), such as .
                Fluid Retention, Localised Intraabdominal Fluid Collection, Pain

                This Death side effect was reported by a consumer or non-health professional from INDIA. A 23-year-old patient (weight:NA) experienced the following symptoms/conditions: chronic myeloid leukaemia. The patient was prescribed Glivec (dosage: 400 Mg, Unk), which was started on NS. Concurrently used drugs: NA. When starting to take Glivec the consumer reported the following symptoms:
                • Fluid Retention
                • Localised Intraabdominal Fluid Collection
                • Pain
                These side effects may potentially be related to Glivec.
                Gastrooesophageal Reflux Disease

                This is a Seroquel Xr side effect report of a 59-year-old patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: depression, who was treated with Seroquel Xr (dosage:NA, start time: Jan 01, 2009), combined with: NA., and developed a serious reaction and a Death side effect. The patient presented with:
                • Gastrooesophageal Reflux Disease
                which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Seroquel Xr treatment in patients suffering from depression, resulting in Death.

                This report suggests a potential Xeloda Death side effect(s) that can have serious consequences. A 67-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): breast cancer metastatic and used Xeloda (dosage: NA) starting Dec 27, 2011. Soon after starting Xeloda the patient began experiencing various side effects, including:
                  Drugs used concurrently:NA. Although Xeloda demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
                  Neoplasm Malignant

                  This Death problem was reported by a physician from UNITED STATES. A 81-year-old patient (weight: NA) was diagnosed with the following medical condition(s): rheumatoid arthritis.On NS a consumer started treatment with Remicade (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Remicade, the patient experienced the following unwanted symptoms /side effects:
                  • Neoplasm Malignant
                  Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.

                  This is a Clozapine side effect report of a 67-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: schizophrenia and was treated with Clozapine (dosage: NA) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
                    This opens a possibility that Clozapine could cause Death and that some female patients may be more susceptible.
                    Cellulitis, Encephalopathy, Renal Failure, Cardiac Failure Congestive, Dyspnoea, Depression, Respiratory Distress

                    A 53-year-old patient (weight: NA) from UNITED STATES with the following symptoms: coronary artery bypass started Trasylol treatment (dosage: 1 Ml Test Dose, 200 Ml Pump Prime, Followed By Conitinuous Infusion Of 50 Ml/hr) on Jul 12, 2006. Soon after starting Trasylol treatment, the consumer experienced several side effects, including:
                    • Cellulitis
                    • Encephalopathy
                    • Renal Failure
                    • Cardiac Failure Congestive
                    • Dyspnoea
                    • Depression
                    • Respiratory Distress
                    . Concurrently used drugs:
                    • Thrombin (10000 U, Unk)
                    • Lidocaine (Unk)
                    • Etomidate (Unk)
                    • Nitroglycerin (Unk)
                    • Coreg
                    • Captopril
                    • Lasix
                    • Red Blood Cells (3 U, Unk)
                    The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Trasylol side effects, such as Death.

                    This Death side effect was reported by a health professional from THAILAND. A 84-year-old female patient (weight:NA) experienced the following symptoms/conditions: osteoporosis.The patient was prescribed Aclasta (dosage: 5 Mg,), which was started on NS. Concurrently used drugs: NA..When starting to take Aclasta the consumer reported symptoms, such as:
                      These side effects may potentially be related to Aclasta.

                      This is a report of a 73-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: aplastic anaemia, who was treated with Aranesp (dosage: 500 Mug, Q3wk, start time: Jul 19, 2011), combined with:
                      • Taxol
                      and developed a serious reaction and side effect(s). The consumer presented with:
                        which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aranesp treatment in female patients, resulting in Death side effect.

                        This report suggests a potential Zometa side effect(s) that can have serious consequences. A 81-year-old female patient (weight: NA) from THAILAND was diagnosed with the following symptoms/conditions: metastases to bone and used Zometa (dosage: 4 Mg, Qmo) starting NS. Soon after starting Zometa the patient began experiencing various side effects, including:
                          Drugs used concurrently: NA. Although Zometa demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.

                          This problem was reported by a health professional from UNITED STATES. A 52-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: multiple sclerosis. On Jan 16, 2012 this consumer started treatment with Tysabri (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Tysabri, the patient experienced the following unwanted symptoms/side effects:
                            Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
                            Diarrhoea, Neutropenia, Mucosal Inflammation

                            This is a report of a 75-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: colorectal cancer and was treated with Capecitabine (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
                            • Diarrhoea
                            • Neutropenia
                            • Mucosal Inflammation
                            This opens a possibility that Capecitabine treatment could cause the above reactions, including Death, and some subjects may be more susceptible.
                            Post Procedural Complication

                            A female patient (weight: NA) from CANADA with the following symptoms/conditions: crohn's disease started Humira treatment (dosage: NA) on Mar 15, 2010. Soon after starting Humira treatment, the subject experienced various side effects, including:
                            • Post Procedural Complication
                            Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Humira.
                            Therapeutic Response Unexpected, Tinnitus, Low Density Lipoprotein Abnormal, Platelet Count Decreased

                            A female patient from UNITED STATES (weight: NA) experienced symptoms, such as: lipids increased and was treated with Lipitor(dosage: 10 Mg, 1x/day). The treatment was initiated on Jan 01, 2002. After that a consumer reported the following side effect(s):
                            • Therapeutic Response Unexpected
                            • Tinnitus
                            • Low Density Lipoprotein Abnormal
                            • Platelet Count Decreased
                            Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Lipitor efficacy:
                            • Atacand (16 Mg, 1x/day (yrs))

                            In this report, Exelon was administered for the following condition: dementia alzheimer's type.A consumer from BRAZIL (weight: NA) started Exelon treatment (dosage: NA) on Sep 01, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
                              A possible interaction with other drugs could have contributed to this reaction:
                              • Risperidone
                              Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Exelon treatment could be related to the listed above side effect(s).
                              Escherichia Test Positive, Febrile Neutropenia, White Blood Cell Count Decreased

                              This is a report of the following Gleevec side effect(s):
                              • Escherichia Test Positive
                              • Febrile Neutropenia
                              • White Blood Cell Count Decreased
                              A 65-year-old patient from US (weight: NA) presented with the following condition: chronic myeloid leukaemia,acute lymphocytic leukaemia and received a treatment with Gleevec (dosage: NA) starting: May 04, 2010.The following concurrently used drugs could have generated interactions:
                              • R-hcvad
                              The patient was hospitalized.This report suggests that a Gleevec treatment could be associated with the listed above side effect(s).

                              This Revatio report was submitted by a 68-year-old female consumer from CANADA (weight: NA). The patient was diagnosed with: pulmonary arterial hypertension and Revatio was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
                                Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Revatio treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

                                This is a report of a possible correlation between Votrient use and the following symptoms/side effect(s):
                                  which could contribute to an assessment of Votrient risk profile.A 58-year-old female consumer from UNITED STATES (weight: NA) was suffering from malignant soft tissue neoplasm and was treated with Votrient (dosage: 800mg Per Day) starting Mar 26, 2012.Other concurrent medications: NA.

                                  A patient from (weight: NA) presented with the following symptoms: NA and after a treatment with (dosage: NA) experienced the following side effect(s):
                                    The treatment was started on NS. was used in combination with the following drugs: NA.This report could alert potential consumers.
                                    Dental Caries, Hypercholesterolaemia, Loose Tooth, Pathological Fracture, Osteoradionecrosis, Vomiting, Nausea, Osteonecrosis Of Jaw

                                    In this report, a 66-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Fosamax side effect.The patient was diagnosed with osteoporosis,osteopenia. After a treatment with Fosamax (dosage: NA, start date: Jan 01, 2003), the patient experienced the following side effect(s):
                                    • Dental Caries
                                    • Hypercholesterolaemia
                                    • Loose Tooth
                                    • Pathological Fracture
                                    • Osteoradionecrosis
                                    • Vomiting
                                    • Nausea
                                    • Osteonecrosis Of Jaw
                                    The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Fosamax treatment.
                                    Weight Increased

                                    This is a report of a female patient from UNITED STATES (weight: NA), who used Fentanyl Citrate (dosage: NA) for a treatment of neck pain,anxiety,back pain,arthritis. After starting a treatment on Jan 01, 2009, the patient experienced the following side effect(s):
                                    • Weight Increased
                                    The following drugs could possibly have interacted with the Fentanyl Citrate treatment
                                    • Xanax
                                    • Duragesic-100
                                    • Celebrex
                                    Taken together, these observations suggest that a Fentanyl Citrate treatment could be related to side effect(s), such as Weight Increased.

                                    This Death side effect was reported by a health professional from UNITED STATES. A 70-year-old patient (weight:NA) experienced the following symptoms/conditions: oesophageal carcinoma. The patient was prescribed Nexavar (dosage: NA), which was started on NS. Concurrently used drugs:
                                    • Forteo
                                    When starting to take Nexavar the consumer reported the following symptoms:
                                      These side effects may potentially be related to Nexavar.

                                      This is a Morphine Sulfate side effect report of a 79-year-old female patient (weight:NA) from CROATIA (local name: Hrvatska), suffering from the following symptoms/conditions: cancer pain, who was treated with Morphine Sulfate (dosage:10 Mg, Daily, start time: Jan 01, 2006), combined with:
                                      • Novomix (70 %, Daily)
                                      • Lanitop (0.1 Mg, Daily)
                                      • Fursemid /00032601/ (40 Mg, Q48h)
                                      • Novomix (30 %, Daily)
                                      , and developed a serious reaction and a Death side effect. The patient presented with:
                                        which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Morphine Sulfate treatment in female patients suffering from cancer pain, resulting in Death.
                                        Suicide Attempt, Inadequate Analgesia, Respiratory Depression, Colitis, Rib Fracture, Pyrexia

                                        This report suggests a potential Diazepam Death side effect(s) that can have serious consequences. A female patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): sedation,rash and used Diazepam (dosage: NA) starting Aug 17, 2010. Soon after starting Diazepam the patient began experiencing various side effects, including:
                                        • Suicide Attempt
                                        • Inadequate Analgesia
                                        • Respiratory Depression
                                        • Colitis
                                        • Rib Fracture
                                        • Pyrexia
                                        Drugs used concurrently:
                                        • Fulmeta
                                        • Sedatives
                                        • Halcion
                                        • Silece
                                        • Fentanyl-100
                                        • Nauzelin
                                        • Loperamide Hcl
                                        • Amitriptyline Hcl
                                        Although Diazepam demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.

                                        This Death problem was reported by a consumer or non-health professional from COLOMBIA. A 60-year-old patient (weight: NA) was diagnosed with the following medical condition(s): ophthalmologic treatment.On Jan 30, 2012 a consumer started treatment with Lucentis (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Lucentis, the patient experienced the following unwanted symptoms /side effects:
                                          Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
                                          Vomiting, Nausea

                                          This is a Tykerb side effect report of a 62-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: breast cancer and was treated with Tykerb (dosage: 1250mg Per Day) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
                                          • Vomiting
                                          • Nausea
                                          This opens a possibility that Tykerb could cause Death and that some female patients may be more susceptible.

                                          A 85-year-old patient (weight: NA) from UNITED STATES with the following symptoms: iron deficiency anaemia started Procrit treatment (dosage: Unk) on Oct 01, 2011. Soon after starting Procrit treatment, the consumer experienced several side effects, including:
                                            . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Procrit side effects, such as Death.

                                            This Death side effect was reported by a consumer or non-health professional from UNITED STATES. A 62-year-old patient (weight:NA) experienced the following symptoms/conditions: pulmonary arterial hypertension.The patient was prescribed Tyvaso (dosage: 18 To 54 Micrograms (4 In 1 D), Inhalation), which was started on Jun 20, 2011. Concurrently used drugs: NA..When starting to take Tyvaso the consumer reported symptoms, such as:
                                              These side effects may potentially be related to Tyvaso.

                                              Discuss Death Side Effects



                                              Popular Pages

                                              More Info